biomarkers

You have access
Independent Validation of a Comprehensive Machine Learning Approach Predicting Survival After Radiotherapy for Bone Metastases
CARSTEN NIEDER, BÅRD MANNSÅKER and ROSALBA YOBUTA

Anticancer Research March 2021, 41 (3) 1471-1474; DOI: https://doi.org/10.21873/anticanres.14905
You have access
Neurological Death After Radiotherapy for Brain Metastases: Role of the LabBM Score
CARSTEN NIEDER, BÅRD MANNSÅKER and ROSALBA YOBUTA

Anticancer Research January 2021, 41 (1) 341-345; DOI: https://doi.org/10.21873/anticanres.14781
You have access
Alternative Biomarkers to Predict Tumor Biology in Hepatocellular Carcinoma
PHILLIPE ABREU, RAPHAELLA FERREIRA, VICTOR MINELI, MAURICIO ALVES RIBEIRO, FABIO GONÇALVES FERREIRA, RODRIGO MARTINEZ DE MELLO VIANNA, FLAVIO DANIEL SAAVEDRA TOMASICH and LUIZ ARNALDO SZUTAN

Anticancer Research December 2020, 40 (12) 6573-6784; DOI: https://doi.org/10.21873/anticanres.14682
You have access
Oncogenic miRNAs Identified in Tear Exosomes From Metastatic Breast Cancer Patients
SACHIKO INUBUSHI, HIROKI KAWAGUCHI, SACHIKO MIZUMOTO, TOMONARI KUNIHISA, MOTOI BABA, YUKIYA KITAYAMA, TOSHIFUMI TAKEUCHI, ROBERT M. HOFFMAN and RYOHEI SASAKI

Anticancer Research June 2020, 40 (6) 3091-3096; DOI: https://doi.org/10.21873/anticanres.14290
You have access
Two Malignancies With Differential Responses to Immune Checkpoint Inhibitors: A Case Report
SE YOUNG HAN, BALKRISHNA N. JAHAGIRDAR and ARKADIUSZ Z. DUDEK

Anticancer Research May 2020, 40 (5) 2821-2826; DOI: https://doi.org/10.21873/anticanres.14255
You have access
A New Model Applied for Evaluating a Rhenium-diselenium Drug: Breast Cancer Cells Stimulated by Cytokines Induced from Polynuclear Cells by LPS
VIJAY VEENA, ADHIKESAVAN HARIKRISHNAN, BASAVEGOWDA LAKSHMI, SUNALI KHANNA, DIDIER DESMAELE and PHILIPPE COLLERY

Anticancer Research April 2020, 40 (4) 1915-1920; DOI: https://doi.org/10.21873/anticanres.14146
You have access
Stratification of Prognosis in Patients With Ampullary Carcinoma After Surgery by Preoperative Platelet-to-lymphocyte Ratio and Conventional Tumor Markers
HIROMICHI KAWAIDA, HIROSHI KONO, HIDETAKE AMEMIYA, NAOHIRO HOSOMURA, MITSUAKI WATANABE, RYO SAITO, SUGURU MARUYAMA, HIROKI SHIMIZU, SHINJI FURUYA, HIDENORI AKAIKE, YOSHIHIKO KAWAGUCHI, MAKOTO SUDO, MASANORI MATUSDA, JUN ITAKURA, HIROKO SHINDO, EI TAKAHASHI, SHINICHI TAKANO, MITSUHARU FUKASAWA, TADASHI SATOU, TADAO NAKAZAWA, NOBUYUKI ENOMOTO, HIDEKI FUJII and DAISUKE ICHIKAWA

Anticancer Research December 2019, 39 (12) 6923-6929; DOI: https://doi.org/10.21873/anticanres.13913
You have access
N-acetylgalactosamine-6-sulfatase (GALNS), Similar to Glycodelin, Is a Potential General Biomarker for Multiple Malignancies
MING-LUNG HO, WEI-KE KUO, LICHIEH J. CHU, I-HSIN YEH, CHUNG-WEI FAN, HSIN-I CHANG, CHO-LI YUAN, TING-YU CHOU, HOANG-YANG CHEN, SHIH-WEI YANG, LIANG-CHE CHANG, MINZHEN LUO, TIMOTHY H. WU, YI-FENG I. CHANG, CHIA-JUNG YU, CHUNG-CHING HUA and WAILAP V. NG

Anticancer Research November 2019, 39 (11) 6317-6324; DOI: https://doi.org/10.21873/anticanres.13842
You have access
Activation of Hedgehog Signaling in Aggressive Hepatic Hemangioma in Newborns and Infants
DANIELLE WENDLING-KEIM, CHRISTIAN VOKUHL, CHRISTOPH WALZ, LYNN RIEDER, RAINER GRANTZOW, DIETRICH VON SCHWEINITZ, ROLAND KAPPLER and MICHAEL BERGER

Anticancer Research May 2019, 39 (5) 2351-2360; DOI: https://doi.org/10.21873/anticanres.13352
You have access
Annexin A2 and S100A10 as Candidate Prognostic Markers in Epithelial Ovarian Cancer
MARIA V. CHRISTENSEN, CLAUS HØGDALL, STEFFEN G. JENSEN, NOOR LOKMAN, CARMELA RICCIARDELLI, IB J. CHRISTENSEN, PERNILLE CHRISTIANSEN, JULIE BRASK, MONA A. KARLSEN, THERESE K. NISSEN, KIRSTEN M. JOCHUMSEN and ESTRID HØGDALL

Anticancer Research May 2019, 39 (5) 2475-2482; DOI: https://doi.org/10.21873/anticanres.13367

Main menu

User menu

Search

biomarkers

Pages